Dow reports first quarter 2022 results

MIDLAND, Mich., April 21, 2022 --

FINANCIAL HIGHLIGHTS
  • GAAP earnings per share (EPS) was $2.11; Operating EPS¹ was $2.34, compared to $1.36 in the year-ago period. Operating EPS excludes certain items in the quarter, totaling $0.23 per share, primarily due to asset-related charges.
  • Net sales were $15.3 billion, up 28% versus the year-ago period, reflecting gains in all operating segments, businesses and regions. Sequentially, net sales were up 6%, driven by gains in Performance Materials & Coatings and Packaging & Specialty Plastics.
  • Local price increased 28% versus the year-ago period, with gains in all operating segments, businesses and regions. Sequentially, local price increased 2%, primarily driven by silicones and polyurethanes.
  • Volume increased 3% versus the year-ago period, with gains in all operating segments and in the U.S. & Canada and Latin America. Sequentially, volume was also up 5%, reflecting strong demand for silicones and polyethylene applications.
  • Equity earnings were $174 million, down $50 million from the year-ago period, primarily driven by impacts from planned maintenance activity at Sadara. Equity earnings were down $50 million from the prior quarter driven by lower polyethylene and MEG margins in Asia Pacific.
  • GAAP Net Income was $1.6 billion. Operating EBIT1 was $2.4 billion, up $865 million from the year-ago period with gains in all operating segments. Sequentially, operating EBIT increased 7%, led by improvements in Performance Materials & Coatings and Industrial Intermediates & Infrastructure as higher prices and lower planned maintenance activity more than offset higher raw material and energy costs.
  • Cash provided by operating activities – continuing operations was $1.6 billion, up $1.8 billion2 year-over-year due to increased earnings and an elective pension contribution in the year-ago period. Sequentially, cash provided by operating activities decreased $945 million as higher dividends from joint ventures were more than offset by working capital on increased sales and raw material costs. Free cash flow1 was $1.3 billion.
  • Returns to shareholders totaled $1.1 billion in the quarter, comprised of $513 million in dividends and $600 million in share repurchases.

SUMMARY FINANCIAL RESULTS


      Three Months Ended Mar 31      

Three Months Ended Dec 31

In millions, except per share amounts

1Q22

1Q21

vs. SQLY

[B / (W)]

4Q21

vs. PQ

[B / (W)]

Net Sales

$15,264

$11,882

$3,382

$14,364

$900

GAAP Income, Net of Tax

$1,552

$1,006

$546

$1,761

$(209)

Operating EBIT¹

$2,419

$1,554

$865

$2,265

$154

Operating EBIT Margin¹

15.9%

13.1%

280 bps  

15.8%

10 bps  

Operating EBITDA¹

$3,171

$2,271

$900

$2,920

$251

GAAP Earnings Per Share

$2.11

$1.32

$0.79

$2.32

$(0.21)

Operating Earnings Per Share¹

$2.34

$1.36

$0.98

$2.15

$0.19

Cash Provided by (Used for)
Operating Activities – Cont. Ops

$1,612

$(228)

$1,840

$2,557

$(945)



1.

Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin, Op. EBITDA, and Free Cash Flow are non-GAAP measures. See page 6 for further discussion.

2.

Cash Provided by Operating Activities – Continuing Operations includes a $1 billion elective pension contribution in the first quarter of 2021.

®TM Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow

CEO QUOTE

Jim Fitterling, chairman and chief executive officer, commented on the quarter:

"Entering our company's 125th year, Team Dow delivered top- and bottom-line growth sequentially and year-over-year in the first quarter, demonstrating the advantage of our differentiated portfolio, feedstock flexibility and continued focus on disciplined execution. Despite higher energy costs, we captured healthy end-market demand and achieved solid volume growth, price gains and margin expansion.

"In addition, today we published our annual benchmarking that demonstrates Dow delivered on our financial targets with top-quartile EBITDA margins, return on capital, free cash flow yield, shareholder remuneration, and debt reduction. We also recently announced a new $3 billion share repurchase program – a direct result of our performance as well as our balanced and disciplined capital allocation approach."

SEGMENT HIGHLIGHTS

Packaging & Specialty Plastics


     Three Months Ended March 31     

Three Months Ended December 31

In millions, except margin
percentages

1Q22

1Q21

vs. SQLY

[B / (W)]

4Q21

vs. PQ

[B / (W)]

Net Sales

$7,627

$6,082

$1,545

$7,189

$438

Operating EBIT

$1,234

$1,228

$6

$1,442

$(208)

Operating EBIT Margin

16.2 %

20.2%

(400)  bps  

20.1%

(390)  bps  

Equity Earnings

$110

$106

$4

$130

$(20)

Packaging & Specialty Plastics segment net sales in the quarter were $7.6 billion, up 25% versus the year-ago period. Local price increased 24% year-over-year with gains in both businesses and all regions. Continued strong end-market demand drove a 4% year-over-year volume increase, with gains in energy sales, olefins, and polyethylene, primarily in the U.S. & Canada. Currency decreased net sales by 3%. On a sequential basis, the segment delivered a 6% net sales increase, driven by robust demand in both businesses, including polyethylene demand, across industrial and consumer packaging applications.

Equity earnings were $110 million, up $4 million compared to the year-ago period. For the principal joint ventures, gains from increased elastomer margins at the Thai joint ventures were offset by lower integrated polyethylene margins at Sadara and the Kuwait joint ventures. On a sequential basis, equity earnings decreased by $20 million due to higher raw material costs impacting polyethylene margins at the principal joint ventures.

Operating EBIT was $1.2 billion, up $6 million versus the year-ago period, with Op. EBIT margins down 400 basis points year-over-year, as price increases in the U.S. & Canada and Latin America were partly offset by rising raw materials and energy costs in all regions. Sequentially, Op. EBIT was down $208 million and Op. EBIT margins declined by 390 basis points, primarily due to higher raw material and energy costs in Europe.

Packaging and Specialty Plastics business delivered higher net sales versus the year-ago period, led by local price gains in all regions as well as in industrial & consumer packaging and flexible food & beverage packaging applications. Volumes declined slightly year-over-year, as growth in the U.S. & Canada was more than offset by declines in Asia Pacific. Sequentially, the business increased revenue on volume gains in all regions. Price increases in functional polymers were more than offset by price declines in polyethylene.

Hydrocarbons & Energy business delivered a net sales increase compared to the year-ago period, driven primarily by higher local prices in olefins and aromatics. Sequentially, sales increased due to higher olefin volume and price, primarily in Europe, the Middle East, Africa and India.

Industrial Intermediates & Infrastructure


     Three Months Ended March 31     

Three Months Ended December 31

In millions, except margin
percentages

1Q22

1Q21

vs. SQLY

[B / (W)]

4Q21

vs. PQ

[B / (W)]

Net Sales

$4,524

$3,607

$917

$4,548

$(24)

Operating EBIT

$661

$326

$335

$595

$66

Operating EBIT Margin

14.6%

9.0%

560 bps  

13.1%

150 bps  

Equity Earnings

$62

$115

$(53)

$90

$(28)

Industrial Intermediates & Infrastructure segment net sales in the quarter were $4.5 billion, up 25% versus the year-ago period. Local price improved 29% year-over-year with gains in both businesses and in all regions. Currency decreased sales by 5%. Volume was up 1% year-over-year as improved supply availability from the impacts of Winter Storm Uri in the prior year were offset by planned maintenance activity at Sadara. On a sequential basis, net sales were down 1%, as local price gains in both businesses were offset by the lower supply availability from Sadara.

Equity earnings were $62 million, down $53 million compared to the year-ago period due to lower supply availability from planned maintenance activity at Sadara. On a sequential basis, equity earnings decreased by $28 million due to lower MEG margins.

Operating EBIT was $661 million, an increase of $335 million compared to the year-ago period, primarily due to strong pricing momentum in both businesses, driving Op. EBIT margins up 560 basis points year-over-year. Sequentially, Op. EBIT was up $66 million, and Op. EBIT margins improved by 150 basis points, as strong prices and lower planned maintenance activity offset pressure from higher raw material and energy costs.

Polyurethanes & Construction Chemicals business delivered higher net sales compared to the year-ago period, driven by local price gains in all regions and across all key value chains. Volume declined year-over-year, primarily due to the lower supply availability from Sadara. Sequentially, net sales declined as local price gains and strong demand for construction and industrial applications were more than offset by the lower supply availability from Sadara due to planned maintenance activity.

Industrial Solutions business delivered increased net sales year-over-year, with local price gains in all regions.  Volume also increased globally, driven by strong demand in industrial, agriculture and coatings markets, as well as improved supply availability from the impacts of Winter Storm Uri in the year-ago period. Sequential net sales were flat as local price gains and demand growth in the pharmaceutical, mobility and home and industrial cleaning end-markets were offset by the lower supply availability from Sadara.  

Performance Materials & Coatings


     Three Months Ended March 31     

Three Months Ended December 31

In millions, except margin
percentages

1Q22

1Q21

vs. SQLY

[B / (W)]

4Q21

vs. PQ

[B / (W)]

Net Sales

$3,049

$2,123

$926

$2,558

$491

Operating EBIT

$595

$62

$533

$295

$300

Operating EBIT Margin

19.5%

2.9%

1,660 bps  

11.5%

800 bps  

Equity Earnings

$3

$2

$1

$2

$1

Performance Materials & Coatings segment net sales in the quarter were $3 billion, up 44% versus the year-ago period. Local price increased 39% year-over-year, with gains in both businesses and in all regions. Volume increased 8% year-over-year on stronger demand for silicones and coatings applications combined with improved supply availability from the impact of Winter Storm Uri in the year-ago period. Currency decreased net sales by 3%. On a sequential basis, net sales were up 19% with local price gains in both businesses. Volume increased sequentially due to strong consumer demand and increased supply availability of siloxanes upon the completion of planned maintenance activity in the prior quarter.

Operating EBIT was $595 million, compared to $62 million in the year-ago period, as Op. EBIT margins increased 1,660 basis points due to strong price gains and robust demand for both silicones and coatings offerings. Sequentially, Op. EBIT improved $300 million and Op. EBIT margins improved 800 basis points due to local price gains and lower impact from planned maintenance activity.

Consumer Solutions business delivered higher net sales year-over year, with local price gains in all regions and applications. Volume also improved across all regions, driven by improved siloxane supply and strong demand for personal care applications. Sequentially, net sales were up with increases in local price and volume. Improved supply availability of siloxanes versus the prior quarter enabled the business to capture stronger demand across all major end-markets.

Coatings & Performance Monomers business delivered increased net sales compared to the year-ago period, with local price gains in all regions. Volume increased year-over-year on improved supply availability of monomers from the impact of Winter Storm Uri in the year-ago period. Sequentially, the business delivered flat sales as local price gains for architectural coatings were offset by lower monomers volumes due to maintenance activity.

OUTLOOK

"Looking ahead, we see strong demand across our end-markets," said Fitterling. "While the geopolitical environment remains dynamic, our global scale, cost-advantaged positions, and industry-leading feedstock and derivative flexibility continue to enable resilient financial and operating performance. At the same time, we are advancing our strategy to decarbonize and grow underlying earnings by more than $3 billion in the transition to a more sustainable world. Dow is well-positioned to achieve mid-cycle earnings above pre-pandemic levels as we capture increasing demand for low-carbon, sustainable and circular innovations."

Conference Call

Dow will host a live webcast of its first quarter earnings conference call with investors to discuss its results, business outlook and other matters today at 8:00 a.m. ET. The webcast and slide presentation that accompany the conference call will be posted on the events and presentations page of investors.dow.com.

About Dow

Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance (ESG) leadership to achieve profitable growth and deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates 104 manufacturing sites in 31 countries and employs approximately 35,700 people. Dow delivered sales of approximately $55 billion in 2021. References to Dow or the Company mean Dow Inc. and its subsidiaries. For more information, please visit www.dow.com or follow @DowNewsroom on Twitter.

Cautionary Statement about Forward-Looking Statements

Certain statements in this report are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.

Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 ("COVID-19") pandemic and other public health-related risks and events on Dow's business; any sanctions, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between Russia and Ukraine; capital requirements and need for and availability of financing; unexpected barriers in the development of technology, including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to carbon neutrality on the contemplated timeframe; size of the markets for Dow's products and services and ability to compete in such markets; failure to develop and market new products and optimally manage product life cycles; the rate and degree of market acceptance of Dow's products; significant litigation and environmental matters and related contingencies and unexpected expenses; the success of competing technologies that are or may become available; the ability to protect Dow's intellectual property in the United States and abroad; developments related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction, manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety and product stewardship; changes in relationships with Dow's significant customers and suppliers; changes in consumer preferences and demand; changes in laws and regulations, political conditions or industry development; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war including the ongoing conflict between Russia and Ukraine; weather events and natural disasters; disruptions in Dow's information technology networks and systems; and risks related to Dow's separation from DowDuPont Inc. such as Dow's obligation to indemnify DuPont de Nemours, Inc. and/or Corteva, Inc. for certain liabilities.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2021. These are not the only risks and uncertainties that Dow faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an actual event, it could have a material adverse effect on Dow's business. Dow and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

®TM Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow                 

 

Non-GAAP Financial Measures

This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company's segments, including allocating resources. Dow's management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year-over-year results. These non-GAAP measures supplement the Company's U.S. GAAP disclosures and should not be viewed as alternatives to U.S. GAAP measures of performance. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Non-GAAP measures included in this release are defined below. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures section starting on page 11. Dow does not provide forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of pending litigation, unusual gains and losses, foreign currency exchange gains or losses and potential future asset impairments, as well as discrete taxable events, without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

Operating earnings per share is defined as "Earnings per common share - diluted" excluding the after-tax impact of significant items.

Operating EBIT is defined as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items.

Operating EBIT margin is defined as Operating EBIT as a percentage of net sales.

Operating EBITDA is defined as earnings (i.e., "Income before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

Free cash flow is defined as "Cash provided by (used for) operating activities - continuing operations," less capital expenditures. Under this definition, free cash flow represents the cash generated by the Company from operations after investing in its asset base. Free cash flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in the Company's financial planning process.

Cash flow conversion is defined as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes cash flow conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

Operating return on capital (ROC) is defined as net operating profit after tax, excluding the impact of significant items, divided by total average capital, also referred to as ROIC.

 

Dow Inc. and Subsidiaries

Consolidated Statements of Income


In millions, except per share amounts (Unaudited)

Three Months Ended

Mar 31,
2022

Mar 31,
2021

Net sales

$   15,264

$   11,882

     Cost of sales

12,402

10,062

     Research and development expenses

218

194

     Selling, general and administrative expenses

498

366

     Amortization of intangibles

88

101

     Restructuring and asset related charges - net

186

     Equity in earnings of nonconsolidated affiliates

174

224

     Sundry income (expense) - net

148

128

     Interest income

28

8

     Interest expense and amortization of debt discount

167

196

Income before income taxes

2,055

1,323

     Provision for income taxes

503

317

Net income

1,552

1,006

     Net income (loss) attributable to noncontrolling interests

(17)

15

Net income available for Dow Inc. common stockholders

$     1,569

$       991



Per common share data:



     Earnings per common share - basic

$      2.12

$      1.32

     Earnings per common share - diluted

$      2.11

$      1.32




Weighted-average common shares outstanding - basic

734.6

744.8

Weighted-average common shares outstanding - diluted

739.8

749.8

 

Dow Inc. and Subsidiaries

Consolidated Balance Sheets


In millions, except share amounts (Unaudited)

Mar 31,
2022

Dec 31,
2021

Assets



Current Assets



     Cash and cash equivalents

$         3,143

$         2,988

     Accounts and notes receivable:



          Trade (net of allowance for doubtful receivables - 2022: $215; 2021: $54)

7,423

6,841

          Other

2,536

2,713

     Inventories

7,760

7,372

     Other current assets

1,303

934

     Total current assets

22,165

20,848

Investments



     Investment in nonconsolidated affiliates

1,821

2,045

     Other investments (investments carried at fair value - 2022: $1,962; 2021: $2,079)

3,067

3,193

     Noncurrent receivables

454

478

     Total investments

5,342

5,716

Property



     Property

57,707

57,604

     Less: Accumulated depreciation

37,360

37,049

     Net property

20,347

20,555

Other Assets



     Goodwill

8,716

8,764

     Other intangible assets (net of accumulated amortization - 2022: $4,790; 2021: $4,725)

2,761

2,881

     Operating lease right-of-use assets

1,339

1,412

     Deferred income tax assets

1,160

1,358

     Deferred charges and other assets

1,505

1,456

     Total other assets

15,481

15,871

Total Assets

$       63,335

$       62,990

Liabilities and Equity



Current Liabilities



     Notes payable

$              92

$            161

     Long-term debt due within one year

355

231

     Accounts payable:



          Trade

5,769

5,577

          Other

2,772

2,839

     Operating lease liabilities - current

306

314

     Income taxes payable

527

623

     Accrued and other current liabilities

3,233

3,481

     Total current liabilities

13,054

13,226

Long-Term Debt

14,108

14,280

Other Noncurrent Liabilities



     Deferred income tax liabilities

654

506

     Pension and other postretirement benefits - noncurrent

7,320

7,557

     Asbestos-related liabilities - noncurrent

915

931

     Operating lease liabilities - noncurrent

1,092

1,149

     Other noncurrent obligations

6,767

6,602

     Total other noncurrent liabilities

16,748

16,745

Stockholders' Equity



     Common stock (authorized 5,000,000,000 shares of $0.01 par value each;

     issued 2022: 767,064,055 shares; 2021: 764,226,882 shares)

8

8

     Additional paid-in capital

8,217

8,151

     Retained earnings

21,672

20,623

     Accumulated other comprehensive loss

(8,796)

(8,977)

     Unearned ESOP shares

(15)

     Treasury stock at cost (2022: 38,962,213 shares; 2021: 29,011,573 shares)

(2,221)

(1,625)

     Dow Inc.'s stockholders' equity

18,880

18,165

     Noncontrolling interests

545

574

     Total equity

19,425

18,739

Total Liabilities and Equity

$       63,335

$       62,990

 

Dow Inc. and Subsidiaries

Consolidated Statements of Cash Flows


In millions (Unaudited)

Three Months Ended

Mar 31,
2022

Mar 31,
2021

Operating Activities



     Net income

$       1,552

$       1,006

     Adjustments to reconcile net income to net cash provided by (used for) operating activities:



          Depreciation and amortization

752

717

          Provision for deferred income tax

253

144

          Earnings of nonconsolidated affiliates less than (in excess of) dividends received

374

(46)

          Net periodic pension benefit cost

7

23

          Pension contributions

(55)

(1,061)

          Net gain on sales of assets, businesses and investments

(6)

(38)

          Restructuring and asset related charges - net

186

          Other net loss

140

55

     Changes in assets and liabilities, net of effects of acquired and divested companies:



          Accounts and notes receivable

(741)

(866)

          Inventories

(443)

(478)

          Accounts payable

86

611

          Other assets and liabilities, net

(493)

(295)

     Cash provided by (used for) operating activities - continuing operations

1,612

(228)

     Cash used for operating activities - discontinued operations

(9)

(63)

     Cash provided by (used for) operating activities

1,603

(291)

Investing Activities



     Capital expenditures

(315)

(289)

     Investment in gas field developments

(37)

(9)

     Purchases of previously leased assets

(2)

(2)

     Proceeds from sales of property and businesses, net of cash divested

4

9

     Investments in and loans to nonconsolidated affiliates

(6)

     Proceeds from sales of ownership interests in nonconsolidated affiliates

11

     Purchases of investments

(148)

(150)

     Proceeds from sales and maturities of investments

141

428

     Other investing activities, net

(15)

     Cash used for investing activities

(367)

(13)

Financing Activities



     Changes in short-term notes payable

(21)

(47)

     Payments on short-term debt greater than three months

(14)

     Proceeds from issuance of long-term debt

16

29

     Payments on long-term debt

(25)

(164)

     Collections on securitization programs

141

     Purchases of treasury stock

(600)

     Proceeds from issuance of stock

35

127

     Transaction financing, debt issuance and other costs

(1)

     Employee taxes paid for share-based payment arrangements

(35)

(10)

     Distributions to noncontrolling interests

(1)

(8)

     Dividends paid to stockholders

(513)

(521)

     Cash used for financing activities

(1,017)

(595)

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(45)

(48)

Summary



     Increase (decrease) in cash, cash equivalents and restricted cash

174

(947)

     Cash, cash equivalents and restricted cash at beginning of period

3,033

5,108

          Cash, cash equivalents and restricted cash at end of period

$       3,207

$       4,161

     Less: Restricted cash and cash equivalents, included in "Other current assets"

64

28

          Cash and cash equivalents at end of period

$       3,143

$       4,133

 

Dow Inc. and Subsidiaries

Net Sales by Segment and Geographic Region

 


Net Sales by Segment

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Packaging & Specialty Plastics

$     7,627

$     6,082

Industrial Intermediates & Infrastructure

4,524

3,607

Performance Materials & Coatings

3,049

2,123

Corporate

64

70

Total

$   15,264

$   11,882

U.S. & Canada

$     5,537

$     4,028

EMEAI 1

5,512

4,329

Asia Pacific

2,753

2,365

Latin America

1,462

1,160

Total

$   15,264

$   11,882

 

Net Sales Variance by Segment and Geographic Region

Three Months Ended Mar 31, 2022


Local
Price &
Product
Mix

Currency

Volume

Total


Percent change from prior year


Packaging & Specialty Plastics

24 %

(3) %

4 %

25 %


Industrial Intermediates & Infrastructure

29

(5)

1

25


Performance Materials & Coatings

39

(3)

8

44


Total

28 %

(3) %

3 %

28 %


Total, excluding the Hydrocarbons & Energy business

29 %

(3) %

1 %

27 %


U.S. & Canada

24 %

— %

13 %

37 %


EMEAI 1

37

(8)

(2)

27


Asia Pacific

19

(1)

(2)

16


Latin America

24

2

26


Total

28 %

(3) %

3 %

28 %


 

Net Sales Variance by Segment and Geographic Region

Three Months Ended Mar 31, 2022


Local
Price &
Product
Mix

Currency

Volume

Total


Percent change from prior quarter


Packaging & Specialty Plastics

— %

(1) %

7 %

6 %


Industrial Intermediates & Infrastructure

2

(1)

(2)

(1)


Performance Materials & Coatings

9

(1)

11

19


Total

2 %

(1) %

5 %

6 %


Total, excluding the Hydrocarbons & Energy business

2 %

(1) %

4 %

5 %


U.S. & Canada

1 %

— %

6 %

7 %


EMEAI 1

8

(2)

2

8


Asia Pacific

(3)

8

5


Latin America

(1)

(1)


Total

2 %

(1) %

5 %

6 %


1.

Europe, Middle East, Africa and India.

 

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures


Operating EBIT by Segment

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Packaging & Specialty Plastics

$     1,234

$     1,228

Industrial Intermediates & Infrastructure

661

326

Performance Materials & Coatings

595

62

Corporate

(71)

(62)

Total

$     2,419

$     1,554




Depreciation and Amortization by Segment

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Packaging & Specialty Plastics

$       395

$       336

Industrial Intermediates & Infrastructure

150

156

Performance Materials & Coatings

200

218

Corporate

7

7

Total

$       752

$       717




Operating EBITDA by Segment

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Packaging & Specialty Plastics

$     1,629

$     1,564

Industrial Intermediates & Infrastructure

811

482

Performance Materials & Coatings

795

280

Corporate

(64)

(55)

Total

$     3,171

$     2,271




Equity in Earnings (Losses) of Nonconsolidated Affiliates by Segment

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Packaging & Specialty Plastics

$       110

$       106

Industrial Intermediates & Infrastructure

62

115

Performance Materials & Coatings

3

2

Corporate

(1)

1

Total

$       174

$       224




Reconciliation of "Net income" to "Operating EBIT"

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Net income

$     1,552

$     1,006

+ Provision for income taxes

503

317

Income before income taxes

$     2,055

$     1,323

-  Interest income

28

8

+ Interest expense and amortization of debt discount

167

196

-  Significant items

(225)

(43)

Operating EBIT (non-GAAP)

$     2,419

$     1,554

 

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures


Significant Items Impacting Results for the Three Months Ended Mar 31, 2022

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   2,055

$   1,569

$     2.11


Less: Significant items





     Digitalization program costs 4

(41)

(32)

(0.04)

Cost of sales ($38 million);

  R&D ($1 million); SG&A ($2 million)

     Restructuring, implementation costs and
       asset related charges - net 5

(10)

(8)

(0.01)

Cost of sales ($7 million);

  R&D ($2 million); SG&A ($1 million)

     Russia / Ukraine conflict charges 6

(186)

(142)

(0.19)

Restructuring and asset related charges
  - net

     Indemnification and other transaction
       related costs 7

12

12

0.01

Sundry income (expense) - net

     Total significant items

$    (225)

$    (170)

$    (0.23)


Operating results (non-GAAP)

$   2,280

$   1,739

$     2.34


 

Significant Items Impacting Results for the Three Months Ended Mar 31, 2021

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   1,323

$      991

$     1.32


Less: Significant items





     Digitalization program costs 4

(33)

(25)

(0.03)

Cost of sales ($29 million);

  SG&A ($4 million)

     Restructuring, implementation costs and
      asset related charges - net 5

(10)

(8)

(0.01)

Cost of sales ($9 million);

  R&D ($1 million)

     Total significant items

$      (43)

$      (33)

$    (0.04)


Operating results (non-GAAP)

$   1,366

$   1,024

$     1.36


1.

"Income before income taxes."

2.

"Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3.

"Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.

4.

Costs associated with implementing the Company's Digital Acceleration program.

5.

Costs associated with implementing the Company's 2020 Restructuring Program.

6.

Asset related charges including inventory write-downs, bad debt reserves, and impairments of other assets related to the conflict between Russia and Ukraine.

7.

Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

 

Dow Inc. and Subsidiaries

Selected Financial Information and Non-GAAP Measures


Significant Items Impacting Results for the Three Months Ended Dec 31, 2021

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported results

$   2,118

$   1,736

$     2.32


Less: Significant items





     Digitalization program costs 4

(48)

(38)

(0.05)

Cost of sales ($40 million);
  R&D ($2 million); SG&A ($6 million)

     Restructuring, implementation costs and
       asset related charges - net 5

Cost of sales ($11 million);
  R&D ($3 million); SG&A ($2 million);
  offset by Restructuring, goodwill
  impairment and asset related
  charges - net $16 million

     Net gain on divestitures and asset sale

16

16

0.02

Sundry income (expense) - net

     Indemnification and other transaction
       related costs 6

35

35

0.05

Sundry income (expense) - net

     Income tax related items 7

111

0.15

Provision for income taxes on
  continuing operations

       Total significant items

$         3

$      124

$     0.17


Operating results (non-GAAP)

$   2,115

$   1,612

$     2.15


1.

"Income before income taxes"

2.

"Net income available for Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3.

"Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.

4.

Costs associated with implementing the Company's Digital Acceleration program.

5.

Restructuring charges and costs associated with implementing the Company's 2020 Restructuring Program.

6.

Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

7.

Includes reversals of certain tax valuation allowances partially offset by charges related to uncertain tax positions.

 

Reconciliation of Free Cash Flow

Three Months Ended

In millions (Unaudited)

Mar 31,
2022

Mar 31,
2021

Cash provided by (used for) operating activities - continuing operations (GAAP)

$     1,612

$      (228)

Capital expenditures

(315)

(289)

Free cash flow (non-GAAP) 1

$     1,297

$      (517)

1.

Free cash flow in the first quarter of 2021 reflects a $1 billion elective pension contribution.

 

Reconciliation of Cash Flow Conversion

Three Months Ended

In millions (Unaudited)

Jun 30,
2021

Sep 30,
2021

Dec 31,
2021

Mar 31,
2022

Cash provided by operating activities - continuing operations (GAAP)

$  2,021

$  2,719

$  2,557

$  1,612

Operating EBITDA (non-GAAP)

3,573

3,611

2,920

3,171

Cash flow conversion (Operating EBITDA to cash flow from
  operations) (non-GAAP)

56.6  %

75.3  %

87.6  %

50.8  %

Cash flow conversion - trailing twelve months (non-GAAP)


67.1  %

 

For further information, please contact:


Investors:

Pankaj Gupta

pgupta@dow.com

+1 989-638-5265

Media:

Kyle Bandlow

kbandlow@dow.com

+1 989-638-2417



Twitter: https://twitter.com/DowNewsroom 
Facebook: https://www.facebook.com/dow/ 
LinkedIn: http://www.linkedin.com/company/dow-chemical 
Instagram: http://instagram.com/dow_official 

 

SOURCE The Dow Chemical Company